The significance of myelosuppression during therapy with...

Cancer 2004 Vol. 100; Iss. 1

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

Thomas B. Sneed, Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, Mary Beth Rios, B. Nebiyou Bekele, Xian Zhou, Debra Resta, William Wierda, Stefan Faderl, Francis Giles, Jorge E. Cortes
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
100
Year:
2004
Language:
english
Pages:
6
DOI:
10.1002/cncr.11863
File:
PDF, 82 KB
english, 2004
Conversion to is in progress
Conversion to is failed